The Pharmacist: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
The Pharmacist
Largest movements
- Current investments -€30,059
down €30,059 (-40.0%), from €75,166 to €45,107
- Tangible fixed assets -€19,341
down €19,341 (-80.7%), from €23,973 to €4,633
of which Land and buildings: -€13,085
- Receivables within one year -€12,897
down €12,897 (-44.9%), from €28,710 to €15,813
of which Trade receivables: -€12,893
- Receivables after one year -€12,054
down €12,054 (-9.0%), from €134,000 to €121,945
- Cash -€6,169
down €6,169 (-35.9%), from €17,187 to €11,018
mainly Contributions, distributions and other (-€89,000) and Debts after one year (-€26,349)
- Reserves -€38,099
down €38,099 (-61.7%), from €61,733 to €23,635
- Debts after one year -€26,349
down €26,349 (-46.7%), from €56,449 to €30,099
- Tax, wage and social debts -€6,959
down €6,959 (-64.7%), from €10,762 to €3,803
- Other debts -€5,258
down €5,258 (-5.1%), from €103,167 to €97,909
- Current portion of long-term debt -€3,647
down €3,647 (-12.5%), from €29,228 to €25,581
- Gross operating margin +€1,632
up €1,632 (+2.4%), from €69,195 to €70,827
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €280,362 | €199,907 | -€80,454 | -28.7% |
| Fixed assets | 21/28 | €23,973 | €4,633 | -€19,341 | -80.7% |
| Tangible fixed assets | 22/27 | €23,973 | €4,633 | -€19,341 | -80.7% |
| Land and buildings | 22 | €13,085 | - | -€13,085 | |
| Furniture and vehicles | 24 | €10,889 | €4,633 | -€6,256 | -57.5% |
| Current assets | 29/58 | €256,388 | €195,275 | -€61,113 | -23.8% |
| Amounts receivable after more than one year | 29 | €134,000 | €121,945 | -€12,054 | -9.0% |
| Other amounts receivable | 291 | €134,000 | €121,945 | -€12,054 | -9.0% |
| Amounts receivable within one year | 40/41 | €28,710 | €15,813 | -€12,897 | -44.9% |
| Trade receivables | 40 | €28,706 | €15,813 | -€12,893 | -44.9% |
| Other amounts receivable | 41 | €4 | - | -€4 | |
| Current investments | 50/53 | €75,166 | €45,107 | -€30,059 | -40.0% |
| Cash at bank and in hand | 54/58 | €17,187 | €11,018 | -€6,169 | -35.9% |
| Deferred charges and accrued income | 490/1 | €1,325 | €1,391 | +€66 | +5.0% |
| Total equity and liabilities | 10/49 | €280,362 | €199,907 | -€80,454 | -28.7% |
| Equity | 10/15 | €80,333 | €42,235 | -€38,099 | -47.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €61,733 | €23,635 | -€38,099 | -61.7% |
| Distributable reserves | 133 | €61,733 | €23,635 | -€38,099 | -61.7% |
| Amounts payable | 17/49 | €200,028 | €157,673 | -€42,356 | -21.2% |
| Amounts payable after more than one year | 17 | €56,449 | €30,099 | -€26,349 | -46.7% |
| Financial debts | 170/4 | €56,449 | €30,099 | -€26,349 | -46.7% |
| Amounts payable within one year | 42/48 | €143,580 | €127,573 | -€16,006 | -11.1% |
| Current portion of amounts payable after more than one year | 42 | €29,228 | €25,581 | -€3,647 | -12.5% |
| Trade debts | 44 | €423 | €281 | -€143 | -33.7% |
| Suppliers | 440/4 | €423 | €281 | -€143 | -33.7% |
| Taxes, remuneration and social security | 45 | €10,762 | €3,803 | -€6,959 | -64.7% |
| Taxes | 450/3 | €10,762 | €3,803 | -€6,959 | -64.7% |
| Other amounts payable | 47/48 | €103,167 | €97,909 | -€5,258 | -5.1% |
| Non-recurring operating income | 76A | - | €1,915 | +€1,915 | |
| Remuneration, social security and pensions | 62 | €224 | €479 | +€255 | +114% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,964 | €6,256 | -€708 | -10.2% |
| Other operating charges | 640/8 | €1,091 | €964 | -€127 | -11.6% |
| Gross operating margin | 9900 | €69,195 | €70,827 | +€1,632 | +2.4% |
| Operating profit (loss) | 9901 | €60,916 | €63,128 | +€2,212 | +3.6% |
| Financial income | 75/76B | €4,362 | €3,771 | -€591 | -13.5% |
| Recurring financial income | 75 | €4,362 | €3,771 | -€591 | -13.5% |
| Financial charges | 65/66B | €1,619 | €1,200 | -€419 | -25.9% |
| Recurring financial charges | 65 | €1,619 | €1,200 | -€419 | -25.9% |
| Profit (loss) for the period before taxes | 9903 | €63,659 | €65,699 | +€2,041 | +3.2% |
| Income taxes | 67/77 | €14,557 | €14,798 | +€241 | +1.7% |
| Profit (loss) for the period | 9904 | €49,102 | €50,901 | +€1,799 | +3.7% |
| Profit (loss) for the period to be appropriated | 9905 | €49,102 | €50,901 | +€1,799 | +3.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.